Stock 000153 ANHUI FENGYUAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Anhui Fengyuan Pharmaceutical Co., Ltd.

Equities

000153

CNE0000014X5

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 14/06/2024 am IST 		5-day change 1st Jan Change
5.56 CNY -0.54% Intraday chart for Anhui Fengyuan Pharmaceutical Co., Ltd. -0.89% -16.93%
13/05 Fengyuan Pharma Gets Nod to Register Two Dialysis Solutions MT
25/04 Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 07 June 2024
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023
CI
Fengyuan Pharma Gets Nod to Register Two Dialysis Solutions
MT
Anhui Fengyuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. canceled the acquisition of Anhui Tiger Biotech Co., Ltd. from Anhui Taige Biological Technology Co., Ltd.
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 16, 2023
CI
Anhui Fengyuan Pharmaceutical Announces Cash Dividend for 2022
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend (Tax Included) for 2022
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. agreed to acquire Anhui Tiger Biotech Co., Ltd. from Anhui Taige Biological Technology Co., Ltd.
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. announced a financing transaction
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. signed an equity transfer agreement to acquire Anhui Fengyuan Gelatin Co., Ltd. from BBCA Group Co., Ltd. for approximately CNY 308 million.
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Management Appointments
CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 05 July 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 000153 Stock
  4. News Anhui Fengyuan Pharmaceutical Co., Ltd.